Ranibizumab for diabetic macular edema refractory to multiple prior treatments
Conclusion: Ranibizumab can improve diabetic macular edema refractory to prior treatments of laser photocoagulation, intravitreal triamcinolone acetonide, and bevacizumab.
Source: RETINA - Category: Opthalmology Tags: Original Study Source Type: research
More News: Avastin | Dexamethasone | Diabetes | Endocrinology | Eye Implants | Eyes | Lucentis | Opthalmology | Ranibizumab Injection | Statistics | Study | Triamcinolone